Content continues after advertisement

Canine Hepatozoonosis

Eileen Johnson, DVM, Oklahoma State University

Infectious Disease

|April 2011|Peer Reviewed

Sign in to Print/View PDF

Canine hepatozoonosis, caused by Hepatozoon canis, has been recognized as a mild disease of dogs in India since the early 1900s. It was subsequently seen in southern Europe, southeastern Asia, and Africa and was more recently reported in the Americas.

Canine hepatozoonosis, caused by Hepatozoon canis, has been recognized as a mild disease of dogs in India since the early 1900s. It was subsequently seen in southern Europe, southeastern Asia, and Africa and was more recently reported in the Americas.

American canine hepatozoonosis (ACH) was first reported in the Gulf Coast of Texas in 1978. Because of differences in parasite structure, tissue tropism, clinical signs, laboratory abnormalities, pathologic manifestations, and tick vectors, the North American organism was designated and later confirmed as a new species, H americanum, which is prevalent throughout the southeastern United States.

View and print a Canine Hepatozoonosis: Hepatozoon americanum vs Hepatozoon canis handout detailing the differences between these 2 infections here.

Life Cycle

These Hepatozoon have a 2-host lifecycle. The definitive hosts, Amblyomma maculatum (Figure 1) and Rhipicephalus sanguineus (Figure 2) acquire gamonts (Figure 3) during feeding. Canine intermediate hosts are exposed by ingestion of polysporocystic oocysts (Figure 4) in the tick body cavity or cystozoites (Figure 5) in tissues of a paratenic host; transmission can also occur transplacentally (H canis).

Merogony occurs in tissues of the canine host (Figure 6A, H americanum; Figure 6B, H canis). Released merozoites provoke pyogranulomatous inflammation and vasculitis (Figure 7) that may lead to hypertrophic osteopathy (Figure 8) with ACH. Merozoites enter neutrophils to become gamonts.

Clinical Signs

Disease caused by H americanum is often severe, whereas clinical illness due to H canis is much less serious. Malaise, pyrexia, anemia, myalgia, mucopurulent ocular discharge, and weakness that are nonresponsive to treatment, along with marked neutrophilic leukocytosis (leukocyte count, 20,000–200,000 cells/mm3), periosteal bone proliferation, and muscle atrophy, strongly suggest ACH.

Diagnosis & Treatment

Muscle biopsy, blood smear examination, or polymerase chain reaction testing of blood are used to diagnose H americanum infection while blood smear examination is used to diagnose H canis infection. Current therapies result in clinical remission but are not curative.

View the Canine Hepatozoonosis: Hepatozoon americanum vs Hepatozoon canis handout detailing the differences between these 2 infections.

ACH = American canine hepatozoonosis

For global readers, a calculator to convert laboratory values, dosages, and other measurements to SI units can be found here.

All Clinician's Brief content is reviewed for accuracy at the time of publication. Previously published content may not reflect recent developments in research and practice.

Material from Clinician's Brief may not be reproduced, distributed, or used in whole or in part without prior permission of Educational Concepts, LLC. For questions or inquiries please contact us.

Podcasts

Clinician's Brief:
The Podcast
Listen as host Alyssa Watson, DVM, talks with the authors of your favorite Clinician’s Brief articles. Dig deeper and explore the conversations behind the content here.
Clinician's Brief provides relevant diagnostic and treatment information for small animal practitioners. It has been ranked the #1 most essential publication by small animal veterinarians for 9 years.*

*2007-2017 PERQ and Essential Media Studies

© 2023 Educational Concepts, L.L.C. dba Brief Media ™ All Rights Reserved. Terms & Conditions | DMCA Copyright | Privacy Policy | Acceptable Use Policy